AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 68 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,413,000 | – | 50,000 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 503,504 | $20,568,138 | 15.61% |
Casdin Capital, LLC | 2,084,841 | $85,165,755 | 6.53% |
COWEN AND COMPANY, LLC | 5,129,103 | $209,523,857 | 5.76% |
RTW INVESTMENTS, LP | 8,806,838 | $359,759,332 | 5.57% |
SILVERARC CAPITAL MANAGEMENT, LLC | 517,734 | $21,149,434 | 4.99% |
Propel Bio Management, LLC | 178,500 | $7,291,725 | 4.73% |
Boxer Capital, LLC | 1,727,388 | $70,563,800 | 3.72% |
Avoro Capital Advisors LLC | 6,505,000 | $265,729,250 | 3.54% |
RA Capital Management | 5,400,408 | $220,606,667 | 2.92% |
EAM Global Investors LLC | 116,615 | $4,763,723 | 1.07% |